Then & Now: Chronic Myelogenous Leukemia
Growing Scientific Understanding Drives Transformative Advances in Treatment
Following the introduction of this revolutionary medicine, survival rates nearly tripled for CML patients. Yet, there still remained a need for additional treatment options for CML patients as the medicine did not work for every patient, and in some cases, those who may have responded initially to therapy developed resistance later on. Over the last decade, a variety of new medicines have become available for patients, offering important treatment options. A new report examines the important advances that have been made in the last ten years, as new medicines continue to transform the outlook for CML patients.